
<(From Left) Dr. Minju Jeong,(UCSD), Prof. Byung Kook Lim (UCSD), Prof. Se-Bum Paik (KAIST)>
Drug addiction carries an extremely high risk of relapse, as cravings can be reignited by minor stimuli even long after one has stopped using. Previously, this phenomenon was attributed to a decline in the function of the prefrontal cortex (PFC), which regulates impulses. However, a joint international research team has recently revealed that the cause of addiction relapse is not a simple decline in brain function, but rather an imbalance in specific neural circuits.
KAIST announced on March 9th that a research team led by Prof. Se-Bum Paik from the Department of Brain and Cognitive Sciences and Prof. Byung Kook Lim from the University of California, San Diego (UCSD) has identified the core principle by which specific inhibitory neurons in the prefrontal cortex regulate cocaine-seeking behavior.
In particular, the research team focused on parvalbumin-positive (PV) inhibitory neurons, which regulate the balance of neural signals by suppressing the activity of other neurons in the brain. They confirmed that these cells act as a "brake gate" that controls excitatory signals in the brain and serve as a crucial factor in determining drug-seeking behavior that emerges after withdrawal.
The prefrontal cortex (PFC) of our brain can properly perform its "braking" function to suppress impulses when excitatory and inhibitory signals are in balance. To investigate how chronic drug exposure disrupts this balance, the research team conducted cocaine administration experiments on mice. During this process, they tracked when inhibitory neurons in the PFC were activated and how they sent signals to downstream brain regions.
The experimental results showed that parvalbumin (PV) cells, which account for about 60-70% of the inhibitory neurons in the PFC, were highly active when the mice attempted to seek cocaine. However, when "extinction training"—training to stop seeking the drug—was conducted, the activity of these cells significantly decreased. This demonstrates that the activity patterns of PV cells are not permanently fixed by addiction but can be readjusted through the extinction process.

<Figure 1. Experimental design illustrating cocaine self-administration and longitudinal tracking of prefrontal cortical neural activity during cocaine-seeking behavior>
The research team confirmed that artificially suppressing PV cell activity significantly reduced cocaine-seeking behavior in mice. Conversely, activating these cells caused the drug-seeking behavior to persist even after the extinction process. This effect was specifically observed in drug-addiction behavior and did not appear with general rewards like sugar water. Furthermore, this phenomenon was not observed in somatostatin (SOM) cells—another type of inhibitory neuron—indicating that PV cells selectively regulate drug addiction behavior.

<Figure 2. Comparison of single-neuron activity, population activity patterns, and behavioral modulation of prefrontal inhibitory neurons across different stages of cocaine-seeking behavior>
The team also identified the specific brain circuit through which these PV cells operate. Signals originating from the prefrontal cortex are transmitted to the reward circuit of the Ventral Tegmental Area (VTA), a key brain region related to reward. This pathway emerged as the central channel for regulating addiction behavior, determining whether or not to seek the drug again. In this process, PV neurons act as a "regulatory switch," controlling the flow of signals to influence dopamine signaling and deciding whether to maintain or suppress addictive behavior.
In short, the study revealed that addiction relapse is not due to an overall functional decline of the prefrontal cortex, but is determined by whether PV neurons regulate the neural pathway connecting the PFC to the reward circuit.

<Figure 3. Schematic illustrating the prefrontal–reward circuit mechanism that determines drug-seeking behavior>
Prof. Se-Bum Paik stated, "This research shows that drug addiction is a circuit-level problem arising from a collapse in the regulatory balance of specific neurons and downstream neural circuits. The discovery that parvalbumin (PV) cells act as a 'gate' for addictive behavior will provide a crucial lead for developing precision-targeted treatment strategies in the future."

This study was led by Dr. Minju Jeong (UCSD) as the first author, with Prof. Byung Kook Lim (UCSD) and Prof. Se-Bum Paik (KAIST) serving as co-corresponding authors. The findings were published online on February 26 in Neuron, a premier journal in the field of neuroscience.
This research was conducted with the support of the Basic Research Program in Science and Engineering of the National Research Foundation of Korea.
Researchers have uncovered a clue to why immune checkpoint inhibitors—cancer therapies that release the immune “brakes” exploited by tumors to evade attack—show limited efficacy in some brain tumors. A KAIST research team found that B cell and antibody responses initiated in tumor-draining lymph nodes, rather than T cells alone, are critical to the antitumor effects of anti-CTLA-4 therapy, opening a new avenue for treating intractable brain tumors. KAIST (President
2026-07-20KAIST researchers have begun developing a next-generation brain-robot interface platform that uses human brain signals to control an exoskeleton in real time and sends the tactile and force information sensed by the robot back to the brain. KAIST, led by President Kwang-Hyung Lee, announced on the 25th that research teams led by Professors Kyoungchul Kong and Jung Kim of its Department of Mechanical Engineering, together with Angel Robotics Co., Ltd., have launched the world’s first bid
2026-06-25<(From Left) Dr. Subin Yoon, Ph.D candidate Hyeonggon Cho, Prof. Jae-Hwan Nam, Prof. Young-suk Lee> Since the COVID-19 pandemic, mRNA vaccines have gained attention as a next-generation pharmaceutical technology. mRNA therapeutics work by delivering genetic instructions that enable cells to produce specific proteins for therapeutic effects. However, their efficacy has been reported to decline in elderly individuals or patients with obesity. To address this limitation, Korean researchers
2026-03-10<(From left) Professor Sang Wan Lee, Myoung Hoon Ha, and Dr. Yoondo Sung> Artificial intelligence now plays Go, paints pictures, and even converses like a human. However, there remains a decisive difference: AI requires far more electricity than the human brain to operate. Scientists have long asked the question, “How can the brain learn so intelligently using so little energy?” KAIST researchers have moved one step closer to the answer. KAIST (President Kwang Hyung Lee) an
2026-03-06<Dr. Jung Won Park, (Upper Right) Professor Jeong Ho Lee, Professor Seok-Gu Kang> IDH-mutant glioma, caused by abnormalities in a specific gene (IDH), is the most common malignant brain tumor among young adults under the age of 50. It is a refractory brain cancer that is difficult to treat due to its high recurrence rate. Until now, treatment has focused primarily on removing the visible tumor mass. However, a Korean research team has discovered for the first time that normal brain cell
2026-01-09